Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
3h
The Premier League returns this week after the conclusion of the FA Cup fourth round, and talkSPORT has all the latest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback